$39.99 $0.66 per serving
Product analysis
Extra Strength Ubiquinol 200 mg may support blood-vessel function, with findings limited to selected adults with blood-fat and vessel-function problems. Its cost is favorable for the amount of CoQ10 provided.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality36
CoQ10 is identified, but the accompanying fat type is unspecified. The ingredient name alone does not establish finished-product absorption or equivalence to a particular preparation.
Ingredient Transparency75
Listed amounts and the CoQ10 identity are disclosed. The fat type remains unspecified, limiting a complete comparison of the contents.
Value For Money100
The cost is favorable for the amount of ubiquinol provided. It offers an economical serving within the CoQ10 comparison.
Customer Satisfaction89
Customer ratings are very positive across thousands of reviews. The broad feedback supports favorable satisfaction, without proving benefits for generally healthy users.
Product Focus80
Ubiquinol has limited support for blood-vessel function in selected adults and preparation-specific findings for fatigue. The broader metabolism, inflammation and longevity aims do not establish the same benefits for everyone.
- Format
Softgel - Container
- 60 Softgel(s)
- Per serving
- $0.66
- Also available
Ubiquinol 100 mg$40.05- Customer rating
- 4.8 · 2,729 ratings
Goals
Impact
Highest effect
Coenzyme Q-10 · 200 mg
Ubiquinol is an identified form of CoQ10 with limited preparation-specific support for fatigue relief. CoQ10 participates in cellular energy production, but that mechanism alone does not prove an everyday energy boost. The 200 mg serving meets the saved comparison's amount reference. Clinical disease-cohort findings do not establish the same benefit in generally healthy users, and no absorption advantage is inferred.
How this product is rated for Energy
Ingredient fit93
The relevant ingredients provide a focused connection to energy. Their declared amounts largely meet the saved amount references.
Goal fit
Relevant ingredients dominate the saved energy fit, although links to other goals broaden the product's focus.
Dose adequacy
Declared amounts largely meet the comparison references; reaching them does not prove an additional energy benefit.
Pathways60
The strongest saved connection is mitochondrial energy production. Only this pathway reached the breadth threshold.
Depth
The strongest saved connection is mitochondrial energy production.
Breadth
Only the strongest pathway meets the saved breadth threshold; the other assessed pathways do not.
Evidence95
Coenzyme Q-10 provides the leading evidence contribution in the saved findings. The included preparations met the saved preparation check, which does not establish unconditional fatigue relief.
Evidence strength
Coenzyme Q-10 supplies the leading evidence contribution; its specific population and outcome limitations still apply.
Studied preparation
The included ingredients meet the saved preparation check; this does not prove finished-product efficacy.
Formulation logic100
The included ingredients have no missing required partners, and no configured conflict was matched. Each included amount clears the saved minimum comparison threshold.
Partner coverage
No required partner is missing from the included contributions.
Conflicts
No configured ingredient conflict was matched; this is not a comprehensive safety assessment.
Effective doses
All included ingredients clear the saved minimum amount threshold; this is a comparison cutoff, not proof of effective fatigue treatment.
Impact
Highest effect
Coenzyme Q-10 · 200 mg
CoQ10 is connected to endothelial function and selected blood-pressure or lipid markers. This product supplies 200 mg per serving as identified Kaneka ubiquinol, meeting the saved amount comparison. The supplied ubiquinol findings concern people with dyslipidemia and endothelial dysfunction, so broad applicability remains limited. They do not establish cardiovascular-event prevention or superiority of ubiquinol over other CoQ10 preparations.
How this product is rated for Cardiovascular Support
Ingredient fit93
Identified ubiquinol gives the formula a clear cardiovascular connection with a fully recognized amount.
Goal fit
CoQ10 is the sole counted active, although the product is linked to several goals.
Dose adequacy
The 200 mg ubiquinol serving meets the saved amount reference.
Pathways60
The contribution is concentrated in endothelial function.
Depth
Endothelial nitric-oxide-related function is the strongest area.
Breadth
Only endothelial function reaches substantial coverage.
Evidence88
CoQ10 supplies the evidence contribution, with the identified ubiquinol preparation accepted.
Evidence strength
CoQ10 provides the strongest saved evidence contribution at its declared amount.
Studied preparation
The identified ubiquinol preparation passes the saved check.
Formulation logic100
The counted contributors have no unmet partner requirement, and no evaluated ingredient conflict was identified.
Partner coverage
Every counted contributor can act alone or has its required partner.
Conflicts
No evaluated ingredient conflict applies.
Effective doses
All counted contributors clear the saved minimum amount threshold.
Impact
Moderate effect
Coenzyme Q-10 · 200 mg
Ubiquinol supports mitochondrial energy production and antioxidant defence. The 200 mg amount meets the saved exposure comparison, but the supplied skin-aging trial used a distinct water-soluble preparation and provides no evidence of longer life.
How this product is rated for Longevity
Ingredient fit93
The counted ingredients are closely aligned with the aging-related functions assessed here. The counted amounts meet the saved exposure comparison.
Goal fit
The counted ingredients are closely aligned with the aging-related functions assessed here.
Dose adequacy
The counted amounts meet the saved exposure comparison.
Pathways40
The strongest supported mechanism is mitochondrial energy production, with moderate coverage. One mechanism reaches the saved coverage target; support across the other mechanisms remains limited.
Depth
The strongest supported mechanism is mitochondrial energy production, with moderate coverage.
Breadth
One mechanism reaches the saved coverage target; support across the other mechanisms remains limited.
Evidence30
Coenzyme Q-10 provides the strongest evidence contribution among ingredients counted at a sufficient amount, within the limited outcomes supplied. The counted preparation is not matched to the preparation used in the relevant supplied trials.
Evidence strength
Coenzyme Q-10 provides the strongest evidence contribution among ingredients counted at a sufficient amount, within the limited outcomes supplied.
Studied preparation
The counted preparation is not matched to the preparation used in the relevant supplied trials.
Formulation logic100
The counted ingredients can contribute independently or have their required partner. No configured ingredient conflict was identified in the supplied findings. 1 of 1 counted ingredients meet the saved minimum exposure threshold.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
1 of 1 counted ingredients meet the saved minimum exposure threshold.
Impact
Highest effect
Coenzyme Q-10 · 200 mg
Ubiquinol has limited support for improved blood-vessel function in adults with dyslipidemia and endothelial dysfunction. The supplied trial studied 100 and 200 mg daily for eight weeks without establishing dose superiority or prevention of clinical events. This product declares 200 mg per serving, meeting the preparation-specific amount reference. The identity does not prove finished-product bioequivalence.
How this product is rated for Heart Health
Ingredient fit93
The relevant ingredients provide a focused heart-health connection. Declared amounts meet the saved exposure references.
Goal fit
Relevant ingredients dominate the fit; links to other goals broaden the product's focus.
Dose adequacy
Declared amounts meet the saved exposure references without establishing a proven treatment dose.
Pathways60
The strongest connection concerns endothelial nitric-oxide function. One assessed pathway reaches the breadth threshold.
Depth
The strongest saved connection concerns endothelial nitric-oxide function, without establishing a corresponding clinical outcome.
Breadth
One assessed pathway reaches the saved breadth threshold.
Evidence98
Coenzyme Q-10 provides the leading evidence contribution. Included preparations satisfy the saved identity check, which does not establish clinical-event prevention.
Evidence strength
Coenzyme Q-10 supplies the leading contribution, with its population and outcome limits retained.
Studied preparation
Included ingredients satisfy the saved preparation check, without proving efficacy of the finished product.
Formulation logic100
No required partner is missing and no configured conflict was matched. Included ingredients clear the minimum amount comparison.
Partner coverage
No required partner is missing from the included contributions.
Conflicts
No configured ingredient conflict was matched.
Effective doses
Included ingredients clear the minimum amount comparison; this does not establish effective treatment.
Impact
Highest effect
Coenzyme Q-10 · 200 mg
CoQ10 has limited inflammatory-marker evidence from ubiquinone in statin-treated coronary artery disease. This product is named ubiquinol, and the saved findings do not identify a studied preparation match. Its 200 mg per serving is acknowledged, but the ubiquinone results do not establish an equivalent anti-inflammatory effect for ubiquinol.
How this product is rated for Inflammation
Ingredient fit93
Coenzyme Q-10 anchors the included contributions, with amounts reaching the comparison range.
Goal fit
The formula is concentrated on ingredients considered for inflammation-related roles.
Dose adequacy
The declared amounts reach the comparison range; that does not establish a clinical anti-inflammatory effect.
Pathways59
The represented contribution centres on oxidative and mitochondrial stress. Coverage across the other specified routes is limited.
Depth
Oxidative and mitochondrial stress is the strongest represented route; the ingredient-specific clinical limitations still apply.
Breadth
One specified route reaches the required coverage; the other routes add limited breadth.
Evidence63
Coenzyme Q-10 provides the strongest included finding. The product lacks a match to the ubiquinone preparation used in the reviewed trial.
Evidence strength
CoQ10 anchors the finding through limited marker evidence in statin-treated coronary artery disease.
Studied preparation
CoQ10 lacks a studied preparation match, so ubiquinone trial findings cannot establish an equivalent effect for this ubiquinol product.
Formulation logic100
The included ingredients meet the amount and partner checks, with no specified conflict triggered.
Partner coverage
No required supporting partner is missing for the included ingredients.
Conflicts
None of the specified ingredient conflict checks was triggered.
Effective doses
The included ingredients meet the minimum amount comparison; it is not a proven clinical anti-inflammatory dose.
Impact
High effect
Coenzyme Q-10 · 200 mg
CoQ10 helps mitochondria carry out normal energy transfer. That function and studies of metabolic markers do not establish that this serving increases whole-body energy expenditure. The 200 mg amount meets the saved comparison anchor, but it does not prove faster calorie burning. The supplied information does not establish a metabolism advantage for a particular CoQ10 form.
How this product is rated for Metabolism Support
Ingredient fit93
CoQ10 provide the ingredient connections retained in the saved findings. Their amount comparisons describe the declared serving rather than a demonstrated metabolism-boosting regimen.
Goal fit
CoQ10 account for the goal-related ingredient findings, while the product's range of other uses limits its focus on this goal.
Dose adequacy
CoQ10 meet the saved full amount comparisons; these are comparison anchors, not proof of increased energy expenditure.
Pathways54
The strongest saved connection concerns mitochondrial energy and fat oxidation; these mechanisms do not by themselves demonstrate faster whole-body energy expenditure. Only one meets the saved coverage threshold.
Depth
The strongest saved connection concerns mitochondrial energy and fat oxidation; these mechanisms do not by themselves demonstrate faster whole-body energy expenditure.
Breadth
Only one pathway meets the saved coverage threshold, so the mechanistic coverage is narrow.
Evidence75
Coenzyme Q-10 provides the strongest saved evidence finding among the qualifying amounts; this does not itself demonstrate a general metabolism boost.
Evidence strength
Coenzyme Q-10 provides the strongest saved evidence finding among the qualifying amounts; this does not itself demonstrate a general metabolism boost.
Studied preparation
The qualifying ingredients are treated as matching studied preparations in the saved findings; preparation matching alone does not establish a rise in energy expenditure.
Formulation logic100
The retained ingredients have no missing required partner or matched configured conflict. They meet the saved amount criterion, which does not establish additional calorie burning.
Partner coverage
The included ingredient contributions do not lack a required partner; this does not establish extra benefit from combining them.
Conflicts
No configured ingredient conflict was matched in the supplied facts; this finding does not establish overall safety.
Effective doses
All ingredients retained for this amount check meet its comparison criterion; that criterion is not a proven dose for increased calorie burning.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 7 Calorie(s) | |
Fat | 0.5 Gram(s) | |
Kaneka Ubiquinol (Coenzyme Q-10) | 200 mg |
Coenzyme Q-10 · 200 mg OverallScore89
Each serving provides 200 mg of CoQ10, which the evaluation identifies as ubiquinol. The price is about $0.33 per 100 mg, though the stored source field is unmapped.
How this ingredient is rated
Active Ingredient Quality & Bioavailability72
The evaluation identifies ubiquinol, though the stored source field is unmapped. No qualifying enhanced delivery or black pepper extract is identified.
Molecular Form: Ubiquinol vs. Ubiquinone
Ubiquinol appears in the product name and is identified by the evaluation, although the saved source field is unmapped.
Formulation & Absorption Enhancers
No qualifying enhanced-delivery formulation or black pepper extract is identified in the saved facts.
Dose, Safety & Label Transparency100
Each serving provides 200 mg of CoQ10. The amount is disclosed, with no specified additive or filler flagged in the ingredient check.
Clinical Dosage Alignment
The 200 mg per serving aligns well with the evaluation for the identified form.
Label Transparency & Fillers
The CoQ10 amount is disclosed, and the ingredient check flags neither the specified concerning additives nor standard fillers.
Value100
The ingredient costs about $0.33 per 100 mg.
Price Per Effective Serving
The evaluated price is about $0.33 per 100 mg of CoQ10.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
- The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
- Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
- Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
- Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
- Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.